FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea BPC 157: Miracle Healing Peptide or Hidden Danger? FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA releases denial letters for unapproved drugs, a step toward transparency Peptides Lack Reliable Safety Information, Watchdog Warns